Alterations in androgen deprivation enhanced prostate-specific membrane antigen (PSMA) expression in prostate cancer cells as a target for diagnostics and therapy
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Alterations in androgen deprivation enhanced prostate-specific membrane antigen (PSMA) expression in prostate cancer cells as a target for diagnostics and therapy
Authors
Keywords
Prostate-specific membrane antigen, <sup>68</sup>Ga peptide, Prostate cancer, Abiraterone acetate, Androgen receptor, Androgen deprivation
Journal
EJNMMI Research
Volume 5, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-11-17
DOI
10.1186/s13550-015-0145-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- In vitro reproduction and explanation of an abiraterone acetate withdrawal phenomenon.
- (2017) Paul Thelen et al. JOURNAL OF CLINICAL ONCOLOGY
- Heterogeneity of prostate-specific membrane antigen (PSMA) expression in classic and apoptotic circulating tumor cells (CTC) in metastatic castration-resistant prostate cancer (mCRPC).
- (2017) Karen A. Autio et al. JOURNAL OF CLINICAL ONCOLOGY
- Sequencing current therapies in the treatment of metastatic prostate cancer
- (2015) Loana B. Valenca et al. CANCER TREATMENT REVIEWS
- Biphasic 68Ga-PSMA-HBED-CC-PET/CT in patients with recurrent and high-risk prostate carcinoma
- (2015) Carsten-Oliver Sahlmann et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- 68Ga-PSMA PET/CT for restaging recurrent prostate cancer: which factors are associated with PET/CT detection rate?
- (2015) Francesco Ceci et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Evaluation of Hybrid 68Ga-PSMA Ligand PET/CT in 248 Patients with Biochemical Recurrence After Radical Prostatectomy
- (2015) M. Eiber et al. JOURNAL OF NUCLEAR MEDICINE
- Prospective Comparison of 18F-Fluoromethylcholine Versus 68Ga-PSMA PET/CT in Prostate Cancer Patients Who Have Rising PSA After Curative Treatment and Are Being Considered for Targeted Therapy
- (2015) J. J. Morigi et al. JOURNAL OF NUCLEAR MEDICINE
- Switching and withdrawing hormonal agents for castration-resistant prostate cancer
- (2015) David Lorente et al. Nature Reviews Urology
- American Cancer Society prostate cancer survivorship care guidelines
- (2014) Ted A. Skolarus et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Is It Possible That One Patient May Again Experience a Response to Abiraterone Acetate Withdrawal During an Abiraterone Acetate Rechallenge?
- (2014) Francesca Maines et al. EUROPEAN UROLOGY
- Synergistic co-targeting of prostate-specific membrane antigen and androgen receptor in prostate cancer
- (2014) Jose D. Murga et al. PROSTATE
- Influence of androgen deprivation therapy on choline PET/CT in recurrent prostate cancer
- (2013) Rutger J. Dost et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- PSMA as a target for radiolabelled small molecules
- (2013) Matthias Eder et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Comparison of PET imaging with a 68Ga-labelled PSMA ligand and 18F-choline-based PET/CT for the diagnosis of recurrent prostate cancer
- (2013) Ali Afshar-Oromieh et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate Cancer
- (2013) Axel Heidenreich et al. EUROPEAN UROLOGY
- 68Ga-Complex Lipophilicity and the Targeting Property of a Urea-Based PSMA Inhibitor for PET Imaging
- (2012) Matthias Eder et al. BIOCONJUGATE CHEMISTRY
- International Variation in Prostate Cancer Incidence and Mortality Rates
- (2012) Melissa M. Center et al. EUROPEAN UROLOGY
- Radiofluorinated Derivatives of 2-(Phosphonomethyl)pentanedioic Acid as Inhibitors of Prostate Specific Membrane Antigen (PSMA) for the Imaging of Prostate Cancer
- (2012) Keith Graham et al. JOURNAL OF MEDICINAL CHEMISTRY
- Noninvasive measurement of androgen receptor signaling with a positron-emitting radiopharmaceutical that targets prostate-specific membrane antigen
- (2011) M. J. Evans et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Novel Carcinoembryonic-Antigen-(CEA)-Specific Pretargeting System to Assess Tumor Cell Viability after Irradiation of Colorectal Cancer Cells
- (2011) Birgit Meller et al. STRAHLENTHERAPIE UND ONKOLOGIE
- Prostate cancer incidence and mortality trends in 37 European countries: An overview
- (2010) F. Bray et al. EUROPEAN JOURNAL OF CANCER
- Partners in crime: deregulation of AR activity and androgen synthesis in prostate cancer
- (2010) Karen E. Knudsen et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Bioisosterism of urea-based GCPII inhibitors: Synthesis and structure–activity relationship studies
- (2009) Haofan Wang et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Radioactive EGFR Antibody Cetuximab in Multimodal Cancer Treatment: Stability and Synergistic Effects With Radiotherapy
- (2009) Dirk Rades et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- A Series of Halogenated Heterodimeric Inhibitors of Prostate Specific Membrane Antigen (PSMA) as Radiolabeled Probes for Targeting Prostate Cancer
- (2008) K. P. Maresca et al. JOURNAL OF MEDICINAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now